WITTERSWIL, Switzerland, November 29 /PRNewswire/ -- Biolytix AG (http://www.biolytix.ch) signed a service provider agreement with Affymetrix UK Ltd (http://www.affymetrix.com) and offers genomic analysis services for the academic and industrial R&D community under conditions compliant with a stringent quality management system.
Biolytix, one of the leading CRO's for molecular biological analysis in Switzerland has acquired a complete Affymetrix GeneChip(R) instrument system to enhance the range of services offered. Besides standard gene expression analysis services, with this state-of-the-art equipment Biolytix is ready to offer services using the latest generation GeneChip(R) products. These include Exon and Tiling arrays as well as SNP genotyping and gene mapping arrays with potential applications in transcriptome mapping, the analysis of gene regulation as well as genome wide SNP mapping and re-sequencing using standard and custom arrays.
The appointment of Biolytix as an Affymetrix authorized service provider further enhances the strong reputation of the company in the molecular biology service provider community. Current and future customers of Biolytix worldwide have now access to the offerings of Affymetrix via the services provided by the company.
Biolytix AG, specialized in molecular and microbiological analyses, was founded in 1998 and is situated in Witterswil (Switzerland), 12 km south-west of Basel. The team and its scope of activities have been expanding continuously. Biolytix, accredited according to ISO/IEC 17025, offers a wide range of services, the major ambition being to fulfil the customers' expectations through confidential and responsible cooperation. The fields of activity of Biolytix are widely distributed in the pharmaceutical, food and cosmetic industry as well as in the veterinarian, agricultural and human diagnostics.
CONTACT: Adrian Harri, CEO, email@example.com, Biolytix AG,
Benkenstrasse 254, CH-4108 Witterswil, Switzerland, Tel. +41(0)61-7252070,